Oligodendrocyte Transcription Factor 1 (OLIG1) (Middle Region) Peptide
OLIG1
Reactivity: Human, Rat
Host: Synthetic
BP, WB
-
- Target See all OLIG1 products
- OLIG1 (Oligodendrocyte Transcription Factor 1 (OLIG1))
- Protein Region
- Middle Region
- Origin
- Human, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LRRKINSRER KRMQDLNLAM DALREVILPY SAAHCQGAPG RKLSKIATLL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Olig1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- OLIG1 (Oligodendrocyte Transcription Factor 1 (OLIG1))
- Synonyms
- OLIG1 Peptide, BHLHB6 Peptide, BHLHE21 Peptide, AI836478 Peptide, AW494459 Peptide, Bhlhb6 Peptide, Olg-1 Peptide, Oligo1 Peptide, bHLHe21 Peptide, Olg1 Peptide, oligodendrocyte transcription factor 1 Peptide, OLIG1 Peptide, Olig1 Peptide
- Background
-
This gene is a member of the oligodendrocyte lineage gene family which encode basic helix-loop-helix transcription factors. Studies in mice show that it is coexpressed with Olig2 in neural progenitors, and has a role in the development and maturation of oligodendrocytes.
Alias Symbols: Olg1
Protein Size: 261 - Molecular Weight
- 28 kDa
- Gene ID
- 60394
- NCBI Accession
- NM_021770, NP_068538
- UniProt
- Q9WUQ3
-
You are here:
